Metastatic Breast Cancer [clinicaltrials_resource:1a26632b8a842fa1e7cb83412a014122]
GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin [clinicaltrials:NCT00044330]Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin. [clinicaltrials:NCT00051103]clinicaltrials:NCT00065325clinicaltrials:NCT00082095clinicaltrials:NCT00134680Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer [clinicaltrials:NCT00140738]Companion Pharmacogenetic Study to UMCC 9900/9901 [clinicaltrials:NCT00146029]Phase II Study of Tailored-Dose Docetaxel in Metastatic Breast Cancer [clinicaltrials:NCT00148070]Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer [clinicaltrials:NCT00148707]Determine Feasibility of Quantifying Apoptosis and Bcl-2 Expression in CTCs in Women With Metastatic Breast Cancer [clinicaltrials:NCT00156273]A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer [clinicaltrials:NCT00159094]Her-2/Neu in Patients With Metastatic Breast Cancer (AdHERe) [clinicaltrials:NCT00162929]An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine [clinicaltrials:NCT00165880]Safety Study of a New Schedule of Capecitabine and Docetaxel to Treat Cancers [clinicaltrials:NCT00169000]clinicaltrials:NCT00169104Study of the Efficacy and Safety of Letrozole Combined With Trastuzumab in Patients With Metastatic Breast Cancer [clinicaltrials:NCT00171847]Mistletoe Extract in Early or Advanced Breast Cancer, A Feasibility Study [clinicaltrials:NCT00176046]clinicaltrials:NCT00191269Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes [clinicaltrials:NCT00192101]Dendritic Cell Based Therapy of Metastatic Breast Cancer [clinicaltrials:NCT00197925]XELOX for Metastatic Breast Cancer [clinicaltrials:NCT00204776]Serum Proteomics to Predict Gemcitabine Sensitivity in Breast Cancer [clinicaltrials:NCT00212069]Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer [clinicaltrials:NCT00212082]Docetaxel Combined With Ketoconazole in Treatment of Breast Cancer [clinicaltrials:NCT00212095]A Study of Weekly Taxotere and Xeloda in Metastatic Breast Cancer [clinicaltrials:NCT00214864]Capecitabine and Oxaliplatin in Treating Patients With Metastatic Breast Cancer [clinicaltrials:NCT00216021]clinicaltrials:NCT00216073Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma [clinicaltrials:NCT00225056]clinicaltrials:NCT00225758clinicaltrials:NCT00240071Letrozole in the Treatment of 1st and 2nd Line Hormone Receptor Positive Breast Cancer: Pre-therapeutic Risk Assessment [clinicaltrials:NCT00241046]PhII ICb With/Without Erbitux in MBC Pts [clinicaltrials:NCT00248287]Myocet, Docetaxel & Trastuzumab as 1st Line Treatment of Patients With HER-2/Neu Positive Metastatic Breast Cancer [clinicaltrials:NCT00250874]A Phase II Trial of Abraxane™ Given Weekly as a Single Agent in First-line Treatment of Metastatic Breast Cancer [clinicaltrials:NCT00251472]clinicaltrials:NCT00262067Satraplatin for Patients With Metastatic Breast Cancer (MBC) [clinicaltrials:NCT00265655]clinicaltrials:NCT00270413clinicaltrials:NCT00270907clinicaltrials:NCT00274456clinicaltrials:NCT00274469
condition [clinicaltrials_vocabulary:condition]
exclusion criteria [clinicaltrials_vocabulary:exclusion-criteria]
inclusion criteria [clinicaltrials_vocabulary:inclusion-criteria]
Metastatic Breast Cancer [clinicaltrials_resource:1a26632b8a842fa1e7cb83412a014122]
Bio2RDF identifier
1a26632b8a842fa1e7cb83412a014122
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1a26632b8a842fa1e7cb83412a014122
identifier
clinicaltrials_resource:1a26632b8a842fa1e7cb83412a014122
title
Metastatic Breast Cancer
@en
label
Metastatic Breast Cancer [clinicaltrials_resource:1a26632b8a842fa1e7cb83412a014122]
@en